Baltogiannis Giannis G, Tsalikakis Dimitrios G, Mitsi Agathokleia C, Hatzistergos Konstantinos E, Elaiopoulos Dimitrios, Fotiadis Dimitrios I, Kyriakides Zenon S, Kolettis Theofilos M
Department of Cardiology, University of Ioannina, 1 University Avenue, 45110 Ioannina, Greece.
Cardiovasc Res. 2005 Sep 1;67(4):647-54. doi: 10.1016/j.cardiores.2005.04.020.
Endothelin-1 (ET-1) production increases during acute myocardial infarction (MI) and may contribute to the genesis of ventricular tachycardia (VT) and ventricular fibrillation (VF). However, the antiarrhythmic effects of ET-1 receptor blockade, examined shortly after MI, have been debated. In the present study, we examined the effects of such treatment on VT/VF during the first 24 h post-MI.
Thirty-five Wistar rats (223+/-22 g) were randomly allocated to either the ET-1 receptor-A (ETA) antagonist BQ-123 (0.4 mg/kg, BQ-123 group, n=17), or normal saline (control group, n=18) and were subjected to coronary artery ligation. A single-lead electrocardiogram was continuously recorded for 24 h post-MI, using an implanted telemetry system, and episodes of VT/VF were analyzed. Monophasic action potential (MAP) recordings were obtained from the left (LV) and right (RV) ventricular epicardium at baseline, 5 min after treatment and 24 h post-MI.
There were 15.94+/-19.35 episodes/h/rat of VT/VF in the control group and 1.66+/-2.22 in the BQ-123 group (p=0.010), resulting in a lower (p=0.030) arrhythmic mortality in treated animals. The mean episode duration was 7.40+/-7.16 s for the control group and 2.30+/-1.37 s for the BQ-123 group (p=0.011). The maximum decrease in VT/VF was observed during the 1st, 5th and 6th hours post-MI. In the control group, LV MAP duration increased 24 h post-MI, displaying an increased beat-to-beat variation, but remained unchanged in the BQ-123 group.
Acute ETA blockade reduces the incidence of VT/V F during the first 24-h post-MI in the rat, through a decrease in the dispersion of repolarization.
急性心肌梗死(MI)期间内皮素 -1(ET-1)生成增加,可能促成室性心动过速(VT)和心室颤动(VF)的发生。然而,心肌梗死后不久对ET-1受体阻断的抗心律失常作用存在争议。在本研究中,我们研究了这种治疗对心肌梗死后24小时内室性心动过速/心室颤动的影响。
35只Wistar大鼠(223±22 g)被随机分为ET-1受体-A(ETA)拮抗剂BQ-123组(0.4 mg/kg,BQ-123组,n = 17)或生理盐水组(对照组,n = 18),并接受冠状动脉结扎。使用植入式遥测系统在心肌梗死后连续记录单导联心电图24小时,并分析室性心动过速/心室颤动发作情况。在基线、治疗后5分钟和心肌梗死后24小时从左心室(LV)和右心室(RV)心外膜获取单相动作电位(MAP)记录。
对照组室性心动过速/心室颤动发作频率为15.94±19.35次/小时/大鼠(n = 17),BQ-123组为1.66±2.22次/小时/大鼠(n = 18)(p = 0.010),治疗组动物心律失常死亡率较低(p = 0.030)。对照组平均发作持续时间为7.40±7.16秒,BQ-123组为2.30±1.37秒(p = 0.011)。在心肌梗死后第1、5和6小时观察到室性心动过速/心室颤动发作频率下降最多。在对照组中,心肌梗死后24小时左心室MAP持续时间增加,逐搏变化增加,但在BQ-123组中保持不变。
急性ETA阻断通过减少复极离散度降低大鼠心肌梗死后24小时内室性心动过速/心室颤动的发生率。